Fig. 3From: Long-term outcomes of edaravone in amyotrophic lateral sclerosis in South Korea: 72-week observational studyThe mean amyotrophic lateral sclerosis Functional Rating Scale ALSFRS-R scores at each time point during edaravone treatment. The baseline score is the mean (standard deviation) ALSFRS-R for 16 patients, the score at week 24 is the score for 15 patients, the score at week 48 is the score for 11 patients, and the score at week 72 is the score for 11 patientsBack to article page